Changes in Estrogen Receptor (ER), Progesterone Receptor (PgR) and HER2/neu Status During Primary Systemic Chemotherapy in Breast Cancer

被引：0
|
作者：
Tozuka, K. [1 ]
Horiguchi, J. [1 ]
Takata, D. [1 ]
Rokutanda, N. [1 ]
Nagaoka, R. [1 ]
Tokiniwa, H. [1 ]
Kikuchi, M. [1 ]
Satou, A. [1 ]
Takeyoshi, I. [1 ]
机构：
[1] Gunma Univ Hosp, Maebashi, Gunma, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S126 / S127
页数：2
相关论文
共 50 条
  • [41] Changes in Hormone Receptor and Her2 Status After Neoadjuvant Chemotherapy in Breast Cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Yamac, Deniz
    Coskun, Ugur
    Yildiz, Ramazan
    Yaman, Emel
    Ozturk, Banu
    Benekli, Mustafa
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2010, 30 (02): : 469 - 473
  • [42] Changing ER, PgR, and HER2 status between primary and recurrent breast cancer.
    Matsumoto, Akiko
    Takahashi, Maiko
    Hayashida, Tetsu
    Hirose, Shigemichi
    Jinno, Hiromitsu
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [43] Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer
    Babette Siebold Saltzman
    Kathleen E. Malone
    Jean A. McDougall
    Janet R. Daling
    Christopher I. Li
    Breast Cancer Research and Treatment, 2012, 135 : 849 - 855
  • [44] Analysis of estrogen receptor positive (ER+), progesterone receptor negative (PR-) phenotype and HER2 status in breast cancer (BC) patients
    Mitrovic, Slobodanka
    Stankovic, Vesna
    Azanjac, Goran
    Ninkovic, Srdan
    VIRCHOWS ARCHIV, 2007, 451 (02) : 299 - 299
  • [45] Clinical outcomes of estrogen receptor (ER)-negative and progesterone receptor (PgR)-positive invasive breast cancer
    Chan, Melissa
    Chang, Martin
    Gonzalez, Rosa
    Lategan, Belinda
    del Barco, Elvira
    Vera-Badillo, Francisco Emilio
    Quesada, Paula
    Goldstein, Robyn
    Cruz, Ignacio
    Ocana, Alberto
    Cruz, Juan J.
    Amir, Eitan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] Discordance of Estrogen Receptor (ER), Progesterone Receptor (PR) and Her-2/Neu Expression between Primary Breast Carcinoma and Brain Metastasis
    Hooda, S.
    Carter, G.
    Chivukula, M.
    MODERN PATHOLOGY, 2011, 24 : 43A - 43A
  • [47] Discordance of Estrogen Receptor (ER), Progesterone Receptor (PR) and Her-2/Neu Expression between Primary Breast Carcinoma and Brain Metastasis
    Hooda, S.
    Carter, G.
    Chivukula, M.
    LABORATORY INVESTIGATION, 2011, 91 : 43A - 43A
  • [48] Estrogen Receptor, Progesterone Receptor, HER2/neu, P53 and Ki-67 status of Male Breast Carcinomas in Pakistan
    Jamal, Shahid
    Mushtaq, Huma
    Mubarik, Azhar
    Malik, Tariq Masood
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (06) : 1067 - 1070
  • [49] HER2/neu positive status, estrogen receptor, progesterone receptor, and their association with clinico-pathological parameters in North Tunisian breast carcinomas
    Nour, Z.
    Charfi, L.
    Mrad, K.
    Sellami, R.
    Doghri, R.
    Boujelbene, N.
    Abbes, I.
    Driss, M.
    Sassi, S.
    Ben Romdhane, K.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 262 - 262
  • [50] Discordance in hormone receptor and HER2 status in breast cancer during neoadjuvant chemotherapy
    Maeda, S.
    Tohyama, H.
    Tokai, H.
    Kamohara, Y.
    Nagata, Y.
    Fujioka, H.
    Itoh, M.
    BREAST, 2011, 20 : S73 - S73
12345